People · Operator
Named in public records as an officer, director or promoter · active 2010–2023 · Healthtech, Robotics, Software / Tech, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Limber Health, Inc. | — | Healthtech | Series B | $16.1M | $225.2M | 2022 |
| Slip Robotics, Inc. | — | Robotics | Series A | $16.0M | $79.3M | 2022 |
| Cypress.io, Inc. | — | Software / Tech | Series A | $14.8M | $257.1M | 2015 |
| Saleo, Inc. | — | Other Technology | Series A | $13.4M | $91.4M | 2022 |
| Yesler Solutions, Inc. | — | Other Technology | Series A | $10.0M | $59.2M | 2020 |
| Interactive Advisory Software Inc | — | Other Technology | Series A | $8.6M | $130.1M | 2010 |
| FortifyData, Inc. | — | Other Technology | Series A | $7.4M | $83.1M | 2021 |
| Pointivo, Inc. | — | Other Technology | Seed | $5.4M | $136.3M | 2015 |
| Geodex, Inc. | — | Other Technology | Seed | $2.7M | $25.6M | 2023 |
| Sequr, Inc. | — | Other Technology | Seed | $2.5M | $20.4M | 2017 |
Blake Patton at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Blake Patton on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Christopher Smith | 1 | 15 |
| Michael Galgon | 1 | 14 |
| Jonathan Hallett | 1 | 10 |
| Justin Wright-Eakes | 1 | 10 |
| Joseph Floyd | 1 | 9 |
| Michael Cohn | 1 | 8 |
| David Cummings | 1 | 8 |
| Gardiner W. Garrard, III | 1 | 5 |
| Michael Droesch | 1 | 5 |
| Robert Barton | 1 | 4 |
| Sean M. Banks | 1 | 4 |
| Andrew Dorman | 1 | 3 |
| Brian Mann | 1 | 3 |
| Thiago Olson | 1 | 3 |
| ROBERT C. MORRELL | 1 | 2 |
| Esteban Reyes | 1 | 2 |
| Ramon Castro | 1 | 2 |
| Philip Boyer | 1 | 2 |
| Randall Kent | 1 | 1 |
| Dan Ciprari | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.